Bella Thornton-Clark

Bella regularly advises companies ranging from early stage start-ups to late stage unicorns on a wide range of corporate matters. Bella started her career as a venture capital lawyer in San Francisco before moving to London. Her clients value her commercial insight into trends and norms in the Californian start-up market. Bella's practice is focused on technology start-ups with particular emphasis on consumer goods, SaaS, healthcare, and fintech.

Expertise

Services et Groupes

Capital-risque

Capital investissement

Fusions et acquisitions d’entreprises et marchés financiers internationaux

Corporate venture capital

Stratégies de sortie (capital-risque)

Participation des salariés et des cadres

Tours de table et phases de financement de croissance consécutifs

Conseil aux startups

Conseil aux fonds

M&A

Secteurs

Technologie, Médias et Communications (TMC)

Sciences de la vie et Santé

Fintech

Software

Biotech

CV

Since 2024 Senior Associate, Taylor Wessing

2022 - 2024 Associate, Taylor Wessing

2020 - 2022 Associate, Gunderson Dettmer, San Francisco

2019 - 2020 Associate, Kirkland & Ellis, San Francisco

2019 Admission to California Bar

2019 J.D. University of Texas School of Law

Carrière

Since 2024 Senior Associate, Taylor Wessing

2022 - 2024 Associate, Taylor Wessing

2020 - 2022 Associate, Gunderson Dettmer, San Francisco

2019 - 2020 Associate, Kirkland & Ellis, San Francisco

Formation

2019 Admission to California Bar

2019 J.D. University of Texas School of Law

Experience

Advising gene therapy company AlveoGene on its complex spinout and launch investment

We have advised AlveoGene, a new UK gene therapy company on its complex spinout from the Gene Therapy Consortium of Imperial College and the Universities of Oxford and Edinburgh focusing on rare respiratory diseases, as well as on its seed round investment.

Press release

Colin McCall

Ross McNaughton

Bella Thornton-Clark